From: The Newfoundland and Labrador Bariatric Surgery Cohort Study: Rational and Study Protocol
Study Measures | Source | Variable | Time frame (s) |
---|---|---|---|
Socio-demographics/Lifestyle | Patient Interview | Age, sex, ethnicity, current marital status, highest level of education, occupation, current employment status, current household income level, smoking status (current, past, never) | Pre-surgery |
Anthropometric | Standardized Case Report Form | Weight1, height2, BMI3 | Pre-surgery, 3, 6, 12, 18, 24 months and annually thereafter |
Medical History/Self-reported baseline comorbid conditions | Standardized Case Report Form | Diabetes, hypertension, dyslipidemia, sleep apnea, NAFLD, PCOS, etc. | Pre-surgery |
Assessment of obesity-related comorbid conditions to evaluate changes in comorbid status | Standardized Case Report Form Patient Interview | Diabetes, hypertension, dyslipidemia, NAFLD, PCOS | 3, 6, 12, 18, 24 months and annually thereafter PCOS will be assessed at 12 months only |
Medication use | Standardized Case Report Form | Prescribed and over-the-counter medications (name, type, dosage, frequency and duration) | Pre-surgery, 3, 6, 12, 18, 24 months and annually thereafter |
Clinical characteristics | Standardized Case Report Form | Blood pressure4, heart rate | Pre-surgery, 3, 6, 12, 18, 24 months and annually thereafter |
Laboratory values | Meditech laboratory module | HbA1c, fasting blood glucose, insulin level, creatinine, fasting lipid panel (including total cholesterol, LDL, HDL, triglycerides), high sensitivity (hs) CRP, GGT, albumin, total bilirubin, ALP, ALT, total protein, ferritin, hemoglobin, MCV, TSH, 25-OH D, Vitamin B12 | Pre-surgery, 3, 6, 12, 18, 24 months and annually thereafter |
Health-related QoL | Validated surveys | SF 12v2, EQ‐5D, IWQoL‐Lite | Pre-surgery, 6, 12, 18, 24 months |
Operative data | Clinical database and chart review | Minor and major complications | During surgery and up to 30 days post-surgery |